The move is designed to help the New Zealand device company accelerate distribution of its sensor following the opening of a U.S. office in San Mateo, California, earlier this year.
New Zealand remote monitoring company for respiratory conditions, Adherium, has opened up offices in San Mateo to pave the way for its expansion to the U.S. market.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The FDA has cleared the third iteration of Adherium's adherence monitoring tool, this time for the AstraZeneca Symbicort inhaler for people with asthma and COPD.
Of the five major respiratory inhaler companies in the U.S., Propeller Health has now signed three. The latest addition, Novartis, gives Propeller an edge as it works to claim market share in the 'smart inhaler' sector projected to be worth $854 million per year by 2025.